Daewoong pharmaceutical Co.,Ltd

Daewoong pharmaceutical Co.,Ltd

069620.KS
Daewoong pharmaceutical Co.,LtdKR flagKSE
130,000.00
KRW
+400.00
(+0.31%)
1.50TMarket Cap
Apr 28Next Earn

Daewoong pharmaceutical Co.,Ltd (069620.KS) Stock Splits

Learn about Daewoong pharmaceutical Co.,Ltd's most recent 103-for-100 basis stock split on December 27, 2012. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Daewoong pharmaceutical Co.,Ltd's most recent stock split

Split Date: 2012-12-27
Split Ratio: 103:100
Price Before Split: $48513.00
Price After Split: $47100.00

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 1.03 times more shares (a 103:100 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Daewoong pharmaceutical Co.,Ltd's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2012-12-27103:100No$48513.00$47100.00
2011-12-28103:100No$29921.38$29049.88
2010-12-29103:100No$46555.63$45199.64
2010-03-31103:100No$51499.40$49999.42
2009-03-31103:100No$54074.15$52499.18
2008-03-31103:100No$111752.82$108497.89

About Daewoong pharmaceutical Co.,Ltd

Company overview and industry information

Daewoong pharmaceutical Co.,Ltd (069620.KS) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 103-for-100 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Drug Manufacturers - Specialty & Generic
Go to Daewoong pharmaceutical Co.,Ltd Summary

Last updated: 4/26/2025

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.